MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 6, 2013, Pages 3756-3766

  Kuo, Po Lin ^a,b   Liao, Szi Hui ^a   Hung, Jen Yu ^b   Huang, Ming Shyan ^b   Hsu, Ya Ling ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Lung cancer; mir 33a; OPG; Osteoclastogenesis; PTHrP

Indexed keywords

COLONY STIMULATING FACTOR 1; INTERLEUKIN 8; LUCIFERASE; MICRORNA; MICRORNA 33A; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS INHIBITION; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

BONE NEOPLASMS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTERLEUKIN-8; LUNG NEOPLASMS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OSTEOCLASTS; OSTEOPROTEGERIN; PARATHYROID HORMONE-RELATED PROTEIN; RANK LIGAND; RNA, NEOPLASM;

EID: 84876012965     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.02.022     Document Type: Article

References (36)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J. Clin. 61 2011 212 236
2. M. Zükin Epidermal growth factor receptor inhibitors in non-small cell lung cancer: current status and future perspectives Rev. Assoc. Med. Bras. 58 2012 263 268
3. R.J. Weiss, and R. Wedin Surgery for skeletal metastases in lung cancer Acta Orthop. 82 2011 96 101
4. K.O. Rove, and E.D. Crawford Metastatic cancer in solid tumors and clinical outcome: skeletal-related events Oncology (Williston Park) 23 2009 21 27
5. J.A. Sterling, J.R. Edwards, T.J. Martin, and G.R. Mundy Advances in the biology of bone metastasis: how the skeleton affects tumor behavior Bone 48 2011 6 15
6. N.A. Sims, and J.H. Gooi Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption Semin. Cell Dev. Biol. 19 2008 444 451
7. A. Hiraki, H. Ueoka, A. Bessho, Y. Segawa, N. Takigawa, K. Kiura, K. Eguchi, T. Yoneda, M. Tanimoto, and M. Harada Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia Cancer 95 2002 1706 1713
8. S. Kitazawa, and R. Kitazawa RANK ligand is a prerequisite for cancer-associated osteolytic lesions J. Pathol. 198 2002 228 236
9. R.J. Thomas, T.A. Guise, J.J. Yin, J. Elliott, N.J. Horwood, T.J. Martin, and M.T. Gillespie Breast cancer cells interact with osteoblasts to support osteoclast formation Endocrinology 140 1999 4451 4458
10. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, M. Goto, S.I. Mochizuki, E. Tsuda, T. Morinaga, N. Udagawa, N. Takahashi, T. Suda, and K. Higashio A novel molecular mechanism modulating osteoclast differentiation and function Bone 25 1999 109 113
11. I.D. Jansen, J.A. Vermeer, V. Bloemen, J. Stap, and V. Everts Osteoclast fusion and fission Calcif. Tissue Int. 90 2012 515 522
12. D.L. Lacey, E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y.X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W.J. Boyle Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176
13. M.C. Vella, E.Y. Choi, S.Y. Lin, K. Reinert, and F.J. Slack The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3′UTR Genes Dev. 18 2004 132 137
14. M.R. Fabian, N. Sonenberg, and W. Filipowicz Regulation of mRNA translation and stability by microRNAs Annu. Rev. Biochem. 79 2010 351 379
15. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 6 2006 857 866
16. K.J. Png, N. Halberg, M. Yoshida, and S.F. Tavazoie A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells Nature 481 2011 190 194
17. S.H. Najafi-Shoushtari, F. Kristo, Y. Li, T. Shioda, D.E. Cohen, R.E. Gerszten, and A.M. Näär MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis Science 328 2010 1566 1569
18. N. Wijesekara, L.H. Zhang, M.H. Kang, T. Abraham, A. Bhattacharjee, G.L. Warnock, C.B. Verchere, and M.R. Hayden miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets Diabetes 61 2012 653 658
19. M. Thomas, K. Lange-Grünweller, U. Weirauch, D. Gutsch, A. Aigner, A. Grünweller, and R.K. Hartmann The proto-oncogene Pim-1 is a target of miR-33a Oncogene 31 2012 918 928
20. A. Gujral, D.W. Burton, R. Terkeltaub, and L.J. Deftos Parathyroid hormone-related protein induces interleukin 8 production by prostate cancer cells via a novel intracrine mechanism not mediated by its classical nuclear localization sequence Cancer Res. 61 2001 2282 2288
21. Y. Lu, R. Govindan, L. Wang, P.Y. Liu, B. Goodgame, W. Wen, A. Sezhiyan, J. Pfeifer, Y.F. Li, X. Hua, Y. Wang, P. Yang, and M. You MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer Carcinogenesis 33 2012 1046 1054
22. M. Boeri, U. Pastorino, and G. Sozzi Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis Cancer J. 268 2012 268 274
23. G. Monego, L. Lauriola, S. Ramella, R.M. D'Angelillo, P. Lanza, P. Granone, and F.O. Ranelletti Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 expression in human lung adenocarcinoma. Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 expression in human lung adenocarcinoma Chest 137 2010 898 908
24. T. Miki, S. Yano, M. Hanibuchi, T. Kanematsu, H. Muguruma, and S. Sone Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice Int. J. Cancer 108 2004 511 515
25. A. Vortkamp, K. Lee, B. Lanske, G.V. Segre, H.M. Kronenberg, and C.J. Tabin Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein Science 273 1996 613 622
26. R.W. Johnson, M.P. Nguyen, S.S. Padalecki, B.G. Grubbs, A.R. Merkel, B.O. Oyajobi, L.M. Matrisian, G.R. Mundy, and J.A. Sterling TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling Cancer Res. 71 2011 822 831
27. Y.L. Hsu, M.S. Huang, C.J. Yang, J.Y. Hung, L.Y. Wu, and P.L. Kuo Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway J. Biol. Chem. 286 2011 37335 37346
28. K. Furugaki, Y. Moriya, T. Iwai, K. Yorozu, M. Yanagisawa, K. Kondoh, K. Fujimoto-Ohuchi, and K. Mori Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292 Clin. Exp. Metastasis 2 2011 649 659
29. G. Mountzios, M.A. Dimopoulos, A. Bamias, G. Papadopoulos, E. Kastritis, K. Syrigos, G. Pavlakis, and E. Terpos Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton Acta Oncol. 46 2007 221 229
30. E.E. McGrath OPG/RANKL/RANK pathway as a therapeutic target in cancer J. Thorac. Oncol. 6 2011 1468 1473
31. I. Roato, M. Grano, G. Brunetti, S. Colucci, A. Mussa, O. Bertetto, and R. Ferracini Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement FASEB J. 19 2005 228 230
32. H. Tao, M. Okamoto, M. Nishikawa, H. Yoshikawa, and A. Myoui P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption PLoS One 6 2011 e23199
33. J. Liao, and L.K. McCauley Skeletal metastasis: established and emerging roles of parathyroid hormone related protein (PTHrP) Cancer Metastasis Rev. 25 2006 559 571
34. H. Iguchi, E. Onuma, K. Sato, K. Sato, and E. Ogata Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen Int. J. Cancer 94 2001 24 27
35. S.R. Pine, L.E. Mechanic, L. Enewold, A.K. Chaturvedi, H.A. Katki, Y.L. Zheng, E.D. Bowman, E.A. Engels, N.E. Caporaso, and C.C. Harris Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer J. Natl. Cancer Inst. 103 2011 1112 1122
36. Y.L. Hsu, J.Y. Hung, Y.C. Ko, C.H. Hung, M.S. Huang, and P.L. Kuo Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis Carcinogenesis 31 2010 587 596